Tak-ling IKK activation: "Ub" the judge

Science Signaling

Volumn 3, Issue 105, 2010, Pages

  Wuerzberger Davis, Shell M ^a   Miyamoto, Shigeki ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; POLYUBIQUITIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;

AUTOPHOSPHORYLATION; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RING FINGER MOTIF; SIGNAL TRANSDUCTION; UBIQUITINATION; ZINC FINGER MOTIF; ANIMAL; HUMAN; METABOLISM;

ANIMALS; HUMANS; INTERLEUKIN-1BETA; MAP KINASE KINASE KINASES; NF-KAPPA B; POLYUBIQUITIN; SIGNAL TRANSDUCTION;

EID: 77952294750     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.3105pe3     Document Type: Review

References (22)

1. B. Skaug, X. Jiang, Z. J. Chen, The role of ubiquitin in NF-κB regulatory pathways. Annu. Rev. Biochem. 78, 769-796 (2009).
2. S. Vallabhapurapu, M. Karin, Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733 (2009).
3. K. Yamazaki, J. Gohda, A. Kanayama, Y. Miyamoto, H. Sakurai, M. Yamamoto, S. Akira, H. Hayashi, B. Su, J. Inoue, Two mechanistically and temporally distinct NF-?B activation pathways in IL-1 signaling. Sci. Signal. 2, ra66 (2009).
4. J. Inoue, J. Gohda, T. Akiyama, Characteristics and biological functions of TRAF6. Adv. Exp. Med. Biol. 597, 72-79 (2007).
5. L. Deng, C.Wang, E. Spencer, L. Yang, A. Braun, J.You, C. Slaughter, C. Pickart, Z. J. Chen, Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
6. K. Newton, M. L. Matsumoto, I. E. Wertz, D. S. Kirkpatrick, J. R. Lill, J. Tan, D. Dugger, N. Gordon, S. S. Sidhu, F. A. Fellouse, L. Komuves, D. M. French, R. E. Ferrando, C. Lam, D. Compaan, C. Yu, I. Bosanac, S. G. Hymowitz, R. F. Kelley, V. M. Dixit, Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134, 668-678 (2008).
7. A. Kanayama, R. B. Seth, L. Sun, C. K. Ea, M. Hong, A. Shaito, Y. H. Chiu, L. Deng, Z. J. Chen, TAB2 and TAB3 activate the NF-?B pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004).
8. M. Windheim, M. Stafford, M. Peggie, P. Cohen, Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IκBα kinase. Mol. Cell. Biol. 28, 1783-1791 (2008).
9. N. Kobayashi, Y. Kadono, A. Naito, K. Matsumoto, T. Yamamoto, S. Tanaka, J. Inoue, Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20, 1271-1280 (2001).
10. Z. Cao, J. Xiong, M. Takeuchi, T. Kurama, D. V. Goeddel, TRAF6 is a signal transducer for interleukin- 1. Nature 383, 443-446 (1996).
11. B. Lamothe, A. D. Campos, W. K. Webster, A. Gopinathan, L. Hur, B. G. Darnay, The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem. 283, 24871-24880 (2008).
12. S. Akira, S. Uematsu, O. Takeuchi, Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
13. Q. Huang, J. Yang, Y. Lin, C. Walker, J. Cheng, Z. G. Liu, B. Su, Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5, 98-103 (2004).
14. Y. Di, S. Li, L.Wang, Y. Zhang, M. E. Dorf, Homeostatic interactions between MEKK3 and TAK1 involved in NF-κB signaling. Cell. Signal. 20, 705-713 (2008).
15. C. Schmidt, B. Peng, Z. Li, G. M. Sclabas, S. Fujioka, J. Niu, M. Schmidt-Supprian, D. B. Evans, J. L. Abbruzzese, P. J. Chiao, Mechanisms of proinflammatory cytokine-induced biphasic NF-κB activation. Mol. Cell 12, 1287-1300 (2003).
16. D. Zhang, V. Facchinetti, X. Wang, Q. Huang, J. Qin, B. Su, Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways. EMBO J. 25, 97-107 (2006).
17. J.Yao, T.W. Kim, J. Qin, Z. Jiang, Y. Qian, H. Xiao, Y. Lu, W. Qian, M. F. Gulen, N. Sizemore, J. DiDonato, S. Sato, S. Akira, B. Su, X. Li, Interleukin-1 (IL-1)-induced TAK1-dependent versus MEKK3- dependent NF-κB activation pathways bifurcate at IL-1 receptor-associated kinase modification. J. Biol. Chem. 282, 6075-6089 (2007).
18. I. E. Wertz, K. M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D. L. Boone, A. Ma, E. V. Koonin, V. M. Dixit, De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699 (2004).
19. A. Kovalenko, C. Chable-Bessia, G. Cantarella, A. Israel, D. Wallach, G. Courtois, The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801-805 (2003).
20. E. Trompouki, E. Hatzivassiliou, T. Tsichritzis, H. Farmer, A. Ashworth, G. Mosialos, CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424, 793-796 (2003).
21. T. R. Brummelkamp, S. M. B. Nijman, A. M. G. Dirac, R. Bernards, Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801 (2003).
22. Z. P. Xia, L. Sun, X. Chen, G. Pineda, X. Jiang, A. Adhikari, W. Zeng, Z. J. Chen, Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114-119 (2009).